MicroRNA-34a functions as an anti-metastatic microRNA and suppresses angiogenesis in bladder cancer by directly targeting CD44

MicroRNA-320c inhibits tumorous behaviors of bladder cancer by targeting Cyclin-dependent kinase 6

(2014) Xiao Wang et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

miR-19a acts as an oncogenic microRNA and is up-regulated in bladder cancer

(2014) Yougang Feng et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

miRNA-34a Suppresses Cell Proliferation and Metastasis by Targeting CD44 in Human Renal Carcinoma Cells

(2014) Gan Yu et al.   JOURNAL OF UROLOGY

Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapy

(2014) Heng Li et al.   Molecular Cancer

p53 regulates glucose metabolism by miR-34a

(2013) Hwa-Ryeon Kim et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

MiR-34a targets GAS1 to promote cell proliferation and inhibit apoptosis in papillary thyroid carcinoma via PI3K/Akt/Bad pathway

(2013) Yanfei Ma et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

EpCAM expression in the prostate cancer makes the difference in the response to growth factors

(2013) Go J. Yoshida et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Inversed relationship between CD44 variant and c-Myc due to oxidative stress-induced canonical Wnt activation

(2013) Go J. Yoshida et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Associations between circulating microRNAs (miR-21, miR-34a, miR-122 and miR-451) and non-alcoholic fatty liver

(2013) Hiroya Yamada et al.   CLINICA CHIMICA ACTA

miR-143, miR-222, and miR-452 Are Useful as Tumor Stratification and Noninvasive Diagnostic Biomarkers for Bladder Cancer

(2012) Patricia Puerta-Gil et al.   AMERICAN JOURNAL OF PATHOLOGY

Li-Fraumeni syndrome with simultaneous osteosarcoma and liver cancer: Increased expression of a CD44 variant isoform after chemotherapy

(2012) Go J Yoshida et al.   BMC CANCER

Axillary node metastasis from differentiated thyroid carcinoma with hürthle and signet ring cell differentiation. A case of disseminated thyroid cancer with peculiar histologic findings

(2012) Maria Grazia Chiofalo et al.   BMC CANCER

Delta-tocotrienol suppresses Notch-1 pathway by upregulating miR-34a in nonsmall cell lung cancer cells

(2012) Xiangming Ji et al.   INTERNATIONAL JOURNAL OF CANCER

CD44+/CD24- phenotype contributes to malignant relapse following surgical resection and chemotherapy in patients with invasive ductal carcinoma

(2012) Yan Lin et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Plasma specific miRNAs as predictive biomarkers for diagnosis and prognosis of glioma

(2012) Qiong Wang et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

CirculatingmiR-34alevels are reduced in colorectal cancer

(2012) M. Nugent et al.   JOURNAL OF SURGICAL ONCOLOGY

Immunohistochemical expression of CD44s in renal cell carcinoma lacks independent prognostic significance

(2012) Walter Henriques da Costa et al.   International Braz J Urol

Activation of β-catenin and Akt pathways by Twist are critical for the maintenance of EMT associated cancer stem cell-like characters

(2011) Junlin Li et al.   BMC CANCER

Chromosome 4p16.3 variant modify bladder cancer risk in a Chinese population

(2011) Meilin Wang et al.   CARCINOGENESIS

MicroRNA-34a suppresses malignant transformation by targeting c-Myc transcriptional complexes in human renal cell carcinoma

(2011) Soichiro Yamamura et al.   CARCINOGENESIS

MicroRNAs as regulators of epithelial-mesenchymal transition

(2011) Philip A. Gregory et al.   CELL CYCLE

MicroRNA in Prostate, Bladder, and Kidney Cancer: A Systematic Review

(2011) James W.F. Catto et al.   EUROPEAN UROLOGY

MiR-34a chemosensitizes bladder cancer cells to cisplatin treatment regardless of p53-Rb pathway status

(2011) Ruth L. Vinall et al.   INTERNATIONAL JOURNAL OF CANCER

CD44 splice isoform switching in human and mouse epithelium is essential for epithelial-mesenchymal transition and breast cancer progression

(2011) Rhonda L. Brown et al.   JOURNAL OF CLINICAL INVESTIGATION

miR-34a predicts survival of Ewing's sarcoma patients and directly influences cell chemo-sensitivity and malignancy

(2011) Fumihiko Nakatani et al.   JOURNAL OF PATHOLOGY

The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44

(2011) Can Liu et al.   NATURE MEDICINE

MiR-34a Targeting of Notch Ligand Delta-Like 1 Impairs CD15+/CD133+ Tumor-Propagating Cells and Supports Neural Differentiation in Medulloblastoma

(2011) Pasqualino de Antonellis et al.   PLoS One

Development of a Lung Cancer Therapeutic Based on the Tumor Suppressor MicroRNA-34

(2010) J. F. Wiggins et al.   CANCER RESEARCH

MicroRNA-34a suppresses invasion through downregulation of Notch1 and Jagged1 in cervical carcinoma and choriocarcinoma cells

(2010) Ronald T.K. Pang et al.   CARCINOGENESIS

Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer

(2010) Dmitri Lodygin et al.   CELL CYCLE

OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma

(2010) Pedro P. Medina et al.   NATURE

A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer

(2010) Lambertus A Kiemeney et al.   NATURE GENETICS

Amplification of LAPTM4B and YWHAZ contributes to chemotherapy resistance and recurrence of breast cancer

(2010) Yang Li et al.   NATURE MEDICINE

Origins and Mechanisms of miRNAs and siRNAs

(2009) Richard W. Carthew et al.   CELL

Recurrence and Progression of Disease in Non–Muscle-Invasive Bladder Cancer: From Epidemiology to Treatment Strategy

(2009) Bas W.G. van Rhijn et al.   EUROPEAN UROLOGY

MicroRNAs in colorectal cancer: translation of molecular biology into clinical application

(2009) Ondrej Slaby et al.   Molecular Cancer

Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer

(2009) Xifeng Wu et al.   NATURE GENETICS

Causes and consequences of microRNA dysregulation in cancer

(2009) Carlo M. Croce   NATURE REVIEWS GENETICS

Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells

(2009) K. S. Chan et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Sequence variant on 8q24 confers susceptibility to urinary bladder cancer

(2008) Lambertus A Kiemeney et al.   NATURE GENETICS

Dicer-dependent endothelial microRNAs are necessary for postnatal angiogenesis

(2008) Y. Suarez et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

A microRNA DNA methylation signature for human cancer metastasis

(2008) A. Lujambio et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA